Avricore Health (AVCRF) Other financing activities (2009 - 2024)

Avricore Health (AVCRF) has reported Other financing activities for 13 consecutive years, with $50817.8 the latest figure, recorded in Q3 2024.

• In Q3 2024, Other financing activities changed N/A year-over-year to $50817.8; the TTM figure through Sep 2024 stood at $74622.7 (up 2.55% YoY), while the FY2024 annual figure was $63252.6, up 100.8% from the prior year.
• Other financing activities rose to $50817.8 in Q3 2024 per AVCRF's latest filing, from $12228.0 in the prior quarter.
• Across five years, Other financing activities topped out at $967959.9 in Q1 2021 and bottomed at -$9.2 million in Q4 2021.
• Historically, Other financing activities has averaged -$650973.9 across 5 years, with a median of $19644.5 in 2023.
• Annual changes were most pronounced in 2021 — Other financing activities plunged 187124.85% — and 2022, when it jumped 100.45%.
• Avricore Health's Other financing activities stood at $4935.2 in 2020, then slumped by 187124.85% to -$9.2 million in 2021, then surged by 100.45% to $41255.4 in 2022, then slumped by 72.93% to $11166.8 in 2023, then soared by 355.08% to $50817.8 in 2024.
• Business Quant data shows AVCRF's Other financing activities at $50817.8 in Q3 2024, $12228.0 in Q2 2024, and $11577.0 in Q1 2024.